Cure My Disease

Don't miss your cure!

 Log in / Sign up

Shockwaves aim to zap back pain without drugs

NCT ID NCT07692347

Symptom relief Sponsor: University Hospital Muenster Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 09, 2026 · Last updated Jul 17, 2026 · Updated 3 times

Summary

This trial tests whether focused shockwave therapy can relieve chronic low back pain better than conventional physiotherapy. Shockwaves are directed at painful spots in muscles and connective tissue to relax them and reduce pain. The study includes adults aged 18–70 with low back pain lasting more than 12 weeks. Researchers measure pain levels and mobility to compare the two approaches.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Shockwave therapy
What this could lead to
If effective, shockwave therapy could offer a new, non-invasive option for easing chronic low back pain and improving mobility.
What could go wrong
This is a small early-stage trial with only 44 participants, so results may not apply to everyone. Shockwave therapy may not work better than standard physiotherapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

44 people

The number who actually took part.

Started

Aug 2022

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Chronic low back pain (LBP) of the lumbar spine lasting more than 12 weeks * age between 18 and 70 years * pain stage 1 or 2 according to Gerbershagen * female, male or diverse * capable of giving informed consent Exclusion Criteria: * Severe neurological * vascular * neoplastic or bony disorders, as well as cognitive impairments * according to the judgment and assessment of the examiner * flexisting radicular symptoms (e.g., foot drop).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Low back pain are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Low Back Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Low back pain

Contacts and locations

Locations

  • Institut für Muskuloskelettale Medizin (IMM) Abteilung für Regenerative Muskuloskelettale Medizin

    Münster, North Rhine-Westphalia, 48149, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.